To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

GOOD NEWS REGARDING SSRI … - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on


Journal article
Authors Fredrik Hieronymus
Alexander Lisinski
Jakob Näslund
Elias Eriksson
Published in Acta neuropsychiatrica
Volume 32
Issue 1
Pages 54-56
ISSN 1601-5215
Publication year 2020
Published at Institute of Neuroscience and Physiology, Department of Pharmacology
Pages 54-56
Language en
Keywords SSRI safety, meta-analysis
Subject categories Pharmacology and Toxicology, Neurosciences


In two previous letters on an SSRI meta-analysis conducted by the Copenhagen Trial Unit at Copenhagen University Hospital, we have commented on a large number of errors, almost all of which have tilted the results in an anti-drug direction, that unfortunately mar this publication. While the authors have acknowledged many of these mishaps, and may now be expected to submit an extensive errata list to the journal where their paper was once published, we regretfully note that also their latest contribution to this exchange is surprisingly inaccurate. However, its many shortcomings notwithstanding, their meta-analysis does add to the current literature by confirming that SSRIs do not seem to enhance the risk for suicide or death, and also that these drugs seem to enhance the risk of side effects categorized as serious only in the elderly.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?